Clinical Trial Update: Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial of orteronel maintenance therapy in metastatic castration-resistant prostate cancer patients who had non-progressive disease after first-line doce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Orteronel (Orteronel)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED